X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
polyquad (15) 15
ophthalmology (10) 10
benzalkonium chloride (9) 9
humans (8) 8
index medicus (7) 7
glaucoma (6) 6
male (6) 6
polyquaternium-1 (6) 6
travoprost (6) 6
medicine & public health (5) 5
pharmacology & pharmacy (5) 5
surface active agents (5) 5
analysis (4) 4
antihypertensive agents - administration & dosage (4) 4
cardiology (4) 4
cell survival - drug effects (4) 4
conjunctiva - drug effects (4) 4
endocrinology (4) 4
epithelium, corneal - drug effects (4) 4
female (4) 4
health technology assessment (4) 4
internal medicine (4) 4
latanoprost (4) 4
medicine, research & experimental (4) 4
ocular surface (4) 4
oncology (4) 4
ophthalmic drugs (4) 4
pharmacology/toxicology (4) 4
prostaglandins f, synthetic - administration & dosage (4) 4
rheumatology (4) 4
adult (3) 3
antihypertensive agents - adverse effects (3) 3
benzalkonium compounds - administration & dosage (3) 3
corneal (3) 3
dose-response relationship, drug (3) 3
drug combinations (3) 3
drug therapy (3) 3
middle aged (3) 3
ophthalmic solutions (3) 3
polymers - administration & dosage (3) 3
polymers - adverse effects (3) 3
polymers - toxicity (3) 3
preservative (3) 3
preservatives, pharmaceutical - administration & dosage (3) 3
preservatives, pharmaceutical - toxicity (3) 3
prostaglandins f, synthetic - adverse effects (3) 3
toxicity (3) 3
animals (2) 2
benzalkonium compounds - adverse effects (2) 2
benzalkonium compounds - toxicity (2) 2
bimatoprost (2) 2
cells, cultured (2) 2
cloprostenol - analogs & derivatives (2) 2
conjunctiva - pathology (2) 2
conjunctival (2) 2
conjunctival changes (2) 2
conjunctival epithelium (2) 2
contact lens solutions - adverse effects (2) 2
contact lens solutions - pharmacology (2) 2
contact lenses (2) 2
cornea (2) 2
corneal epithelium (2) 2
corneal staining (2) 2
cross-over studies (2) 2
cytotoxicity (2) 2
disease (2) 2
epithelial cells - drug effects (2) 2
epithelial-cells (2) 2
eye diseases (2) 2
fluorescence (2) 2
genetic structures (2) 2
glaucoma - drug therapy (2) 2
glaucoma, open-angle - drug therapy (2) 2
hp-guar (2) 2
hydrogel, polyethylene glycol dimethacrylate (2) 2
hydrogels (2) 2
hypertension (2) 2
in vitro techniques (2) 2
in-vitro (2) 2
intraocular pressure - drug effects (2) 2
medical colleges (2) 2
ocular hypertension - drug therapy (2) 2
open-angle glaucoma (2) 2
pharmaceutical preservatives (2) 2
polyhexamethylene biguanide (2) 2
preservatives (2) 2
preservatives, pharmaceutical - adverse effects (2) 2
prevalence (2) 2
prospective studies (2) 2
prostaglandin analogs (2) 2
prostaglandins (2) 2
rabbits (2) 2
risk-factors (2) 2
sense organs (2) 2
silicones (2) 2
staining and labeling (2) 2
tear substitute (2) 2
timolol - administration & dosage (2) 2
timolol - adverse effects (2) 2
travoprost - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advances in Therapy, ISSN 0741-238X, 11/2010, Volume 27, Issue 11, pp. 837 - 845
To investigate potentially adverse effects of different topical glaucoma medications and preservatives on cultured ocular epithelial cells.Confluent cultures... 
pharmaceutical preservatives | glaucoma | Rheumatology | Oncology | Internal Medicine | conjunctival epithelium | travoprost | benzalkonium chloride | corneal epithelium | polyquaternium-1 | latanoprost | polyquad | Medicine & Public Health | tafluprost | Pharmacology/Toxicology | Cardiology | Endocrinology | Glaucoma | Corneal epithelium | Polyquad | Benzalkonium chloride | Polyquaternium-1 | Conjunctival epithelium | Tafluprost | Pharmaceutical preservatives | Latanoprost | Travoprost | SYSTEM | MEDICINE, RESEARCH & EXPERIMENTAL | CHANG CONJUNCTIVAL | PRESERVATIVES | BIMATOPROST | TOXICITY | CORNEAL | IN-VITRO | CONJUNCTIVAL CHANGES | PHARMACOLOGY & PHARMACY | Cell Survival - drug effects | Polymers - administration & dosage | Humans | Cells, Cultured | Antihypertensive Agents - administration & dosage | Benzalkonium Compounds - administration & dosage | Glaucoma - drug therapy | Cloprostenol - analogs & derivatives | Preservatives, Pharmaceutical - toxicity | Dose-Response Relationship, Drug | Prostaglandins F, Synthetic - toxicity | Antihypertensive Agents - toxicity | Conjunctiva - drug effects | Prostaglandins F, Synthetic - administration & dosage | Benzalkonium Compounds - toxicity | Polymers - toxicity | Prostaglandins F | Epithelium, Corneal - drug effects | Ophthalmic Solutions | Preservatives, Pharmaceutical - administration & dosage | Administration, Topical | Conjunctiva - cytology | Medical colleges | Prostaglandins | Surface active agents | Analysis | Ophthalmic drugs | Fluorescence | Ophthalmology | Drug therapy | Health technology assessment
Journal Article
Saratovskij Naučno-medicinskij Žurnal, 09/2015, Volume 11, Issue 3, pp. 337 - 341
The purpose was to evaluate the efficacy and tolerability of travoprost and timolol use in the treatment of patients with initial stage of primary open angle... 
histomorphological changes in the corneal tissue | polyquad | primary open-angle glaucoma | benzalkonium chloride
Journal Article
Advances in Therapy, ISSN 0741-238X, 6/2011, Volume 28, Issue 6, pp. 501 - 510
Journal Article
Journal Article
Advances in Therapy, ISSN 0741-238X, 6/2014, Volume 31, Issue 6, pp. 592 - 603
To compare the 24-h intraocular pressure (IOP) control and tolerability of travoprost/timolol benzalkonium chloride (BAK)-free (TTFC) vs. latanoprost/timolol... 
Latanoprost/timolol | OSD | Rheumatology | Polyquad | Internal Medicine | Oncology | 24-h intraocular pressure (IOP) control | Benzalkonium chloride | Fixed combinations | Ocular surface | Travoprost/timolol | Medicine & Public Health | Ophthalmology | Cardiology | Pharmacology/Toxicology | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | POLYQUATERNIUM-1 | RISK-FACTORS | EYE WORKSHOP 2007 | OPEN-ANGLE GLAUCOMA | INTRAOCULAR-PRESSURE CONTROL | DRY EYE | PRESERVED TRAVOPROST | PHARMACOLOGY & PHARMACY | PROSTAGLANDIN ANALOGS | Travoprost - adverse effects | Intraocular Pressure - drug effects | Prospective Studies | Tonometry, Ocular - methods | Humans | Middle Aged | Glaucoma, Open-Angle - diagnosis | Antihypertensive Agents - administration & dosage | Timolol - administration & dosage | Male | Treatment Outcome | Drug Monitoring - methods | Prostaglandins F, Synthetic - adverse effects | Antihypertensive Agents - adverse effects | Glaucoma, Open-Angle - drug therapy | Cross-Over Studies | Drug Synergism | Prostaglandins F, Synthetic - administration & dosage | Female | Neuroprotective Agents - adverse effects | Neuroprotective Agents - administration & dosage | Drug Combinations | Travoprost - administration & dosage | Timolol - adverse effects | Glaucoma | Surface active agents | Analysis | Health technology assessment
Journal Article
Der Ophthalmologe, ISSN 0941-293X, 6/2008, Volume 105, Issue 6, pp. 557 - 562
Die Verwendung von Konservierungsmitteln (z. B. Benzalkoniumchlorid) in pharmazeutischen Tränenersatzmitteln induziert zytotoxische Effekte. Unlängst wurde... 
Konservierungsmittel | Tear substitute | Medicine & Public Health | HP-Guar | Preservative | Polyquad | Zytotoxizität | Cytotoxicity | Ophthalmology | Tränenersatzmittel | HP-guar
Journal Article
Advances in Therapy, ISSN 0741-238X, 4/2011, Volume 28, Issue 4, pp. 311 - 325
The aim of this study was to use a validated acute rabbit model to test the toxicity of a novel formulation of fixed-combination travoprost 0.004%/timolol 0.5%... 
ocular surface toxicity | timolol | Rheumatology | Oncology | Internal Medicine | travoprost | benzalkonium chloride | Xalacom | Duotrav | latanoprost | polyquad | Medicine & Public Health | in vivo | Cardiology | Pharmacology/Toxicology | Endocrinology | In vivo | Ocular surface toxicity | Polyquad | Benzalkonium chloride | Timolol | Latanoprost | Travoprost | MEDICINE, RESEARCH & EXPERIMENTAL | POLYQUATERNIUM-1 | MEDICATIONS | TOXICITY | PREVALENCE | CONJUNCTIVAL | IN-VIVO | PHARMACOLOGY & PHARMACY | GLAUCOMA | IMPRESSION CYTOLOGY | PROSTAGLANDIN ANALOGS | Polymers - administration & dosage | Antihypertensive Agents - administration & dosage | Timolol - administration & dosage | Male | Epithelium, Corneal - pathology | Ocular Hypertension - drug therapy | Conjunctiva - pathology | Prostaglandins F, Synthetic - administration & dosage | Epithelium, Corneal - drug effects | Ophthalmic Solutions | Anti-Bacterial Agents - adverse effects | Polymers - adverse effects | Disease Models, Animal | Timolol - adverse effects | Cell Survival - drug effects | Rabbits | Cloprostenol - adverse effects | Preservatives, Pharmaceutical - adverse effects | Cloprostenol - administration & dosage | Ocular Hypertension - pathology | Benzalkonium Compounds - adverse effects | Benzalkonium Compounds - administration & dosage | Treatment Outcome | Prostaglandins F, Synthetic - adverse effects | Antihypertensive Agents - adverse effects | Cloprostenol - analogs & derivatives | Animals | Conjunctiva - drug effects | Preservatives, Pharmaceutical - administration & dosage | Anti-Bacterial Agents - administration & dosage | Drug Combinations | Immunohistochemistry | Surface active agents | Analysis | Ophthalmic drugs | Health technology assessment
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.